These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34657593)

  • 21. Network Meta-Analysis.
    Watt J; Del Giovane C
    Methods Mol Biol; 2022; 2345():187-201. PubMed ID: 34550592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What have we learned from network meta-analyses applied to critical care?
    Baez-Pravia OV; Montes-Andujar L; Menéndez J; Cardinal-Fernández P
    Minerva Anestesiol; 2019 Apr; 85(4):433-442. PubMed ID: 30735019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative Efficacy of Acalabrutinib in Frontline Treatment of Chronic Lymphocytic Leukemia: A Systematic Review and Network Meta-analysis.
    Davids MS; Waweru C; Le Nouveau P; Padhiar A; Singh G; Abhyankar S; Leblond V
    Clin Ther; 2020 Oct; 42(10):1955-1974.e15. PubMed ID: 33032842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bayesian Methods for Meta-Analyses of Binary Outcomes: Implementations, Examples, and Impact of Priors.
    Al Amer FM; Thompson CG; Lin L
    Int J Environ Res Public Health; 2021 Mar; 18(7):. PubMed ID: 33801771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Borrowing of strength from indirect evidence in 40 network meta-analyses.
    Lin L; Xing A; Kofler MJ; Murad MH
    J Clin Epidemiol; 2019 Feb; 106():41-49. PubMed ID: 30342086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spie charts for quantifying treatment effectiveness and safety in multiple outcome network meta-analysis: a proof-of-concept study.
    Daly CH; Mbuagbaw L; Thabane L; Straus SE; Hamid JS
    BMC Med Res Methodol; 2020 Oct; 20(1):266. PubMed ID: 33115431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Empirical evaluation of SUCRA-based treatment ranks in network meta-analysis: quantifying robustness using Cohen's kappa.
    Daly CH; Neupane B; Beyene J; Thabane L; Straus SE; Hamid JS
    BMJ Open; 2019 Sep; 9(9):e024625. PubMed ID: 31492773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of reporting bias in network meta-analysis of antidepressant placebo-controlled trials.
    Trinquart L; Abbé A; Ravaud P
    PLoS One; 2012; 7(4):e35219. PubMed ID: 22536359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Critical quality evaluation of network meta-analyses in dental care.
    Lee DW; Shin IS
    J Dent; 2018 Aug; 75():7-11. PubMed ID: 29879456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methodological quality assessment of network meta-analysis of drug interventions: implications from a systematic review.
    Tonin FS; Borba HH; Leonart LP; Mendes AM; Steimbach LM; Pontarolo R; Fernandez-Llimos F
    Int J Epidemiol; 2019 Apr; 48(2):620-632. PubMed ID: 30212868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Network meta-analysis from a pairwise meta-analysis design: to assess the comparative effectiveness of oral care interventions in preventing ventilator-associated pneumonia in critically ill patients.
    Sankaran SP; Sonis S
    Clin Oral Investig; 2021 May; 25(5):2439-2447. PubMed ID: 33537946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the clinical effectiveness of treatments for aromatase inhibitor-induced arthralgia in breast cancer patients: a protocol for a systematic review and network meta-analysis.
    Bae K; Song SY
    BMJ Open; 2020 May; 10(5):e033461. PubMed ID: 32371507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequentist performances of Bayesian prediction intervals for random-effects meta-analysis.
    Hamaguchi Y; Noma H; Nagashima K; Yamada T; Furukawa TA
    Biom J; 2021 Feb; 63(2):394-405. PubMed ID: 33164247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative efficacy and acceptability of interventions for major depression in older persons: protocol for Bayesian network meta-analysis.
    Liew TM; Lee CS
    BMJ Open; 2018 Jan; 8(1):e019819. PubMed ID: 29358451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multifaceted graphical display, including treatment ranking, was developed to aid interpretation of network meta-analysis.
    Nevill CR; Cooper NJ; Sutton AJ
    J Clin Epidemiol; 2023 May; 157():83-91. PubMed ID: 36870376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Markov chain approach for ranking treatments in network meta-analysis.
    Chaimani A; Porcher R; Sbidian É; Mavridis D
    Stat Med; 2021 Jan; 40(2):451-464. PubMed ID: 33105517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimal surgical methods to treat intertrochanteric fracture: a Bayesian network meta-analysis based on 36 randomized controlled trials.
    Cheng YX; Sheng X
    J Orthop Surg Res; 2020 Sep; 15(1):402. PubMed ID: 32912279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modelling time-course relationships with multiple treatments: Model-based network meta-analysis for continuous summary outcomes.
    Pedder H; Dias S; Bennetts M; Boucher M; Welton NJ
    Res Synth Methods; 2019 Jun; 10(2):267-286. PubMed ID: 31013000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Participants' outcomes gone missing within a network of interventions: Bayesian modeling strategies.
    Spineli LM; Kalyvas C; Pateras K
    Stat Med; 2019 Sep; 38(20):3861-3879. PubMed ID: 31134664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.